- New Purchases: MRUS,
- Added Positions: ARVN, BPMC, ARWR, FDMT, SPRO, RGNX, AMYT,
- Reduced Positions: QURE,
- Sold Out: DRNA,
For the details of Aquilo Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/aquilo+capital+management%2C+llc/current-portfolio/portfolio
These are the top 5 holdings of Aquilo Capital Management, LLC- S&P 500 ETF TRUST ETF (SPY) - 1,000,000 shares, 53.87% of the total portfolio.
- Spero Therapeutics Inc (SPRO) - 4,964,181 shares, 9.01% of the total portfolio. Shares added by 8.78%
- Blueprint Medicines Corp (BPMC) - 645,539 shares, 7.84% of the total portfolio. Shares added by 23.74%
- Arrowhead Pharmaceuticals Inc (ARWR) - 700,426 shares, 5.27% of the total portfolio. Shares added by 32.68%
- Arvinas Inc (ARVN) - 563,451 shares, 5.25% of the total portfolio. Shares added by 58.85%
Aquilo Capital Management, LLC initiated holding in Merus NV. The purchase prices were between $20 and $32.29, with an estimated average price of $28.39. The stock is now traded at around $25.440000. The impact to a portfolio due to this purchase was 3.23%. The holding were 896,502 shares as of 2021-12-31.
Added: Arvinas Inc (ARVN)Aquilo Capital Management, LLC added to a holding in Arvinas Inc by 58.85%. The purchase prices were between $65.85 and $96.21, with an estimated average price of $81.26. The stock is now traded at around $69.020000. The impact to a portfolio due to this purchase was 1.94%. The holding were 563,451 shares as of 2021-12-31.
Added: Blueprint Medicines Corp (BPMC)Aquilo Capital Management, LLC added to a holding in Blueprint Medicines Corp by 23.74%. The purchase prices were between $94.25 and $115.99, with an estimated average price of $104.74. The stock is now traded at around $66.690000. The impact to a portfolio due to this purchase was 1.5%. The holding were 645,539 shares as of 2021-12-31.
Added: Arrowhead Pharmaceuticals Inc (ARWR)Aquilo Capital Management, LLC added to a holding in Arrowhead Pharmaceuticals Inc by 32.68%. The purchase prices were between $58.09 and $82.51, with an estimated average price of $68.91. The stock is now traded at around $44.250000. The impact to a portfolio due to this purchase was 1.3%. The holding were 700,426 shares as of 2021-12-31.
Added: 4D Molecular Therapeutics Inc (FDMT)Aquilo Capital Management, LLC added to a holding in 4D Molecular Therapeutics Inc by 37.27%. The purchase prices were between $19.56 and $32.94, with an estimated average price of $24.43. The stock is now traded at around $13.970000. The impact to a portfolio due to this purchase was 1.02%. The holding were 1,509,944 shares as of 2021-12-31.
Added: Regenxbio Inc (RGNX)Aquilo Capital Management, LLC added to a holding in Regenxbio Inc by 20.79%. The purchase prices were between $30.19 and $39.06, with an estimated average price of $33.95. The stock is now traded at around $24.620000. The impact to a portfolio due to this purchase was 0.65%. The holding were 1,013,596 shares as of 2021-12-31.
Sold Out: (DRNA)Aquilo Capital Management, LLC sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.
Here is the complete portfolio of Aquilo Capital Management, LLC. Also check out:
1. Aquilo Capital Management, LLC's Undervalued Stocks
2. Aquilo Capital Management, LLC's Top Growth Companies, and
3. Aquilo Capital Management, LLC's High Yield stocks
4. Stocks that Aquilo Capital Management, LLC keeps buying